Physician profile
Muhammad K Khan
NPI 1215234737
$3,907.98
in general payments reported to CMS, 2019-2025
36 companies · $678 in 2025
The $678 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $948 · 2022: $764 · 2023: $615 · 2024: $903 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,105 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,105.25 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $639.75 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $381.32 | 2021-2025 | Repatha, Otezla, Otezla |
| Astellas Pharma US INC | $344.98 | 2021-2024 | Veozah, Myrbetriq |
| Lilly USA, LLC | $322.23 | 2022-2025 | Mounjaro, Jardiance, Kisunla |
| Otsuka America Pharmaceutical, INC. | $313.42 | 2022-2025 | Rexulti, Abilify Maintena |
| Abbvie INC. | $253.96 | 2021-2025 | |
| Pfizer INC. | $153.96 | 2021-2024 | |
| Neurocrine Biosciences, INC. | $138.52 | 2022-2024 | Ingrezza |
| Astrazeneca Pharmaceuticals LP | $135.57 | 2021-2024 | Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $133.84 | 2022-2025 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $104.56 | 2025 | |
| Collegium Pharmaceutical, INC. | $87.47 | 2023-2024 | Belbuca |
| Janssen Pharmaceuticals, INC | $83.89 | 2021 | |
| Dexcom, INC. | $62.08 | 2022-2024 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $59.17 | 2022 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.